David Mansfield, MD
Orthopaedic Surgery · El Paso, TXNPI 1508846734
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 31.4% of the total. 2025 is the largest year on record at $18,654, more than ten times the $782 reported in 2019.
Across 393 payments — averaging $104.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$13K
- Sanara Medtech Inc.$10K
- Stryker$8K
- Arthrex$5K
- Miach Orthopaedics, Inc.$3K
- Nvision Biomedical Technologies, Inc.$833
- plus $2K from 13 others
What the payments were for
- Consulting fees$1,5004%
- Speaking & faculty fees$8,16020%
- Travel & lodging$8,69421%
- Food & beverage$20,12549%
- Education$2,4006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 191 | $12,819 |
| Sanara Medtech Inc. | 5 | $9,847 |
| Stryker | 134 | $7,977 |
| Arthrex | 23 | $4,569 |
| Miach Orthopaedics, Inc. | 3 | $2,977 |
| Nvision Biomedical Technologies, Inc. | 2 | $833 |
| Heraeus Medical, LLC. | 12 | $632 |
| Rattan And Associates | 5 | $318 |
| Johnson & Johnson | 4 | $227 |
| US Implant Solutions, LLC | 1 | $206 |
| Zimmer Biomet | 1 | $122 |
| Avanos Medical | 3 | $97 |
| Spineology Inc. | 1 | $85 |
| Medtronic | 1 | $48 |
| Merck | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Abbott | 1 | $28 |
| Next Science LLC | 1 | $16 |
| Biocomposites Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CellerateRx$9,847
- Journey II$3,166
- REAL INTELLIGENCE$2,640
- MAKO$2,130
- RI.HIP NAVIGATION$2,079
- JOURNEY$2,079
- REDAPT$1,694
- POLARSTEM$1,395
- Legion Revision$1,243
- Tandem$1,243
- OR3O Dual Mobility$1,089
- NAVIO$750
- Suture Anchor$744
- AUTOFIX$404
- Bioinductive Implant with Arthroscopic Delivery System - Medium$384
- Bone Anchors with Arthroscopic Delivery System$379
- Legion$323
- VISIONAIRE$323
- INSPACE$290
- Journey II BCS$276
How this compares
$40,880 in reported general payments places this provider in the 85th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $449 |
| Ibuprofen | 20 | $288 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in El Paso
- Alvaro HernandezEl Paso$672K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.